(Q55406629)

English

Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. (English)

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

1 reference

based on heuristic

inferred from title

author name string

James H Heller

1

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

Gail A Spiridigliozzi

2

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

P Murali Doraiswamy

3

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

Jennifer A Sullivan

4

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

Bythe G Crissman

5

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

Priya S Kishnani

6

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

American Journal of Medical Genetics

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

130A

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

3

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

325-326

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665884

12 August 2018

Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15378553

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic therapy for Down's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15378553

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/AJMG.A.30184

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 July 2018

http://europepmc.org/abstract/PMC/2665884

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55406629&oldid=1503133072"